Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -16 | -28 | -2 | -5 |
| Purchase Sale Intangibles | -3 | N/A | -6 | N/A | N/A |
| Investing Cash Flow | $-34 | $-16 | $-34 | $-2 | $-5 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,270 | 28,603 | 434 | 8,924 | 1,393 |
| Common Stock Repurchased | -61 | -983 | -6 | -86 | -363 |
| Other Financing Activity | 0 | 0 | 0 | 86 | 181 |
| Financing Cash Flow | $2,209 | $27,620 | $428 | $8,924 | $1,212 |
| Exchange Rate Effect | 680 | -1,513 | -115 | 206 | -61 |
| Beginning Cash Position | 24,379 | 5,954 | 7,808 | 1,488 | 3,213 |
| End Cash Position | 20,824 | 24,336 | 5,137 | 7,489 | 1,485 |
| Net Cash Flow | $-4,235 | $19,895 | $-2,556 | $5,795 | $-1,667 |
| Free Cash Flow | |||||
| Capital Expenditure | -37 | -17 | -36 | -2 | -5 |
| Free Cash Flow | -37 | -17 | -36 | -2 | -5 |